证券代码：301515 证券简称：港通医疗 公告编号：2026-003 变更内容 变更前 变更后 经营范围 一般项目：通用设备制造（不含特 种设备制造）；专用设备制造（不 含许可类专业设备制造）；通用零 部件制造；机械零件、零部件加工； 机械电气设备制造；家具制造；机 械设备研发；金属制品研发； 机 械设备销售；金属制品销售；机械 电气设备销售；家具销售；特种设 备销售；第一类医疗器械销售；电 子、机械设备维护（不含特种设 备）。（除依法须经批准的项目外， 一般项目：通用设备制造（不含特 种设备制造）；专用设备制造（不 含许可类专业设备制造）；通用零 部件制造；机械零件、零部件加工； 机械电气设备制造；家具制造；机 械设备研发；金属制品研发；机械 设备销售；金属制品销售：机械电 气设备销售；家具销售；特种设备 销售；第一类医疗器械销售；电子、 机械设备维护（不含特种设备）； 配电开关控制设备制造；配电开关 一、变更情况 四川港通医疗设备集团股份有限公司 关于子公司变更经营范围暨完成工商变更登记的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 四川港通医疗 ...

关于控股子公司变更法人并换发营业执照的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 二、本次变更对公司的影响 本次控股子公司法定代表人变更系公司发展规划需要，有助于优化控股子公 司治理结构；本次控股子公司法定代表人变更不会对公司及控股子公司的生产经 营和盈利能力产生不利影响。 证券代码：301515 证券简称：港通医疗 公告编号：2026-002 四川港通医疗设备集团股份有限公司 近日，四川港通医疗设备集团股份有限公司（以下简称"公司"）控股子公 司成都狄普锐科技有限公司（以下简称"控股子公司"）根据经营管理需要，将 其法定代表人由赵洋变更为任森昊，现已完成工商变更登记手续并取得成都市青 羊区行政审批局核准换发的《营业执照》，现将有关情况公告如下： 一、变更工商信息 变更前法定代表人：赵洋 变更后法定代表人：任森昊 四川港通医疗设备集团股份有限公司董事会 2026 年 3 月 9 日 三、备查文件 成都狄普锐科技有限公司《营业执照》。 特此公告。 ...

融券方面，港通医疗2月26日融券偿还0.00股，融券卖出0.00股，按当日收盘价计算，卖出金额0.00元； 融券余量0.00股，融券余额0.00元，超过近一年60%分位水平，处于较高位。 来源：新浪证券-红岸工作室 2月26日，港通医疗跌0.85%，成交额3335.88万元。两融数据显示，当日港通医疗获融资买入额158.54 万元，融资偿还492.70万元，融资净买入-334.16万元。截至2月26日，港通医疗融资融券余额合计1.36 亿元。 融资方面，港通医疗当日融资买入158.54万元。当前融资余额1.36亿元，占流通市值的7.66%，融资余 额超过近一年90%分位水平，处于高位。 资料显示，四川港通医疗设备集团股份有限公司位于四川省成都市简阳市凯力威工业大道南段356号， 成立日期1998年1月13日，上市日期2023年7月25日，公司主营业务涉及为医疗机构提供以医用气体系统 及医院洁净手术部为核心的医疗专业工程整体方案。主营业务收入构成为：医用洁净装备及系统 55.69%，医用气体装备及系统37.30%，医疗设备及其他产品销售4.06%，运维服务2.81%，其他(补 充)0.14%。 截至2月13日， ...

Core Viewpoint - The company, Sichuan Portong Medical Equipment Group Co., Ltd., specializes in the research, design, manufacturing, integration, and operation services of medical gas equipment and clean equipment systems, with a focus on the medical industry and advanced technologies like IoT [3][7]. Business Overview - The main business segments of the company include medical gas equipment and systems (37.30% of revenue), clean equipment and systems (55.69%), sales of medical devices and other products (4.06%), and operation services (2.81%) [8]. - The company has developed the Portong Cloud Monitoring Platform, which utilizes advanced IoT technology to provide real-time monitoring solutions for medical equipment in hospitals [2]. Market Position - The company has been recognized as a "specialized, refined, distinctive, and innovative" small giant enterprise, indicating its strong market position and innovation capabilities [3]. - As of February 13, the company had 8,585 shareholders, a decrease of 3.74% from the previous period, with an average of 7,637 circulating shares per person, an increase of 3.89% [8]. Financial Performance - For the period from January to September 2025, the company reported a revenue of 344 million yuan, a year-on-year decrease of 30.06%, and a net profit attributable to shareholders of -10.21 million yuan, a decrease of 150.92% [8]. - The company has distributed a total of 48.9973 million yuan in dividends since its A-share listing [9]. Stock Performance - On February 26, the company's stock price fell by 0.85%, with a trading volume of 33.3588 million yuan and a turnover rate of 1.98%, resulting in a total market capitalization of 2.555 billion yuan [1]. - The average trading cost of the stock is 24.84 yuan, with the stock currently near a resistance level of 26.16 yuan, indicating potential for upward movement if this level is surpassed [6].

Core Viewpoint - As of February 25, 2026, the stock price of Kangtong Medical (301515) closed at 25.77 yuan, reflecting a decline of 1.15% with a turnover rate of 2.33% and a trading volume of 15,300 shares, amounting to a total transaction value of 39.53 million yuan [1] Group 1: Financial Performance - For the first three quarters of 2025, Kangtong Medical reported a main revenue of 344 million yuan, representing a year-on-year decrease of 30.06% [3] - The net profit attributable to shareholders was -10.21 million yuan, a year-on-year decline of 150.92% [3] - The net profit excluding non-recurring items was -12.87 million yuan, down 176.82% year-on-year [3] - In Q3 2025, the company achieved a single-quarter main revenue of 79.12 million yuan, which is a year-on-year increase of 42.81% [3] - The single-quarter net profit attributable to shareholders was -1.80 million yuan, a year-on-year decrease of 138.94% [3] - The single-quarter net profit excluding non-recurring items was -2.60 million yuan, down 182.34% year-on-year [3] - The company's debt ratio stands at 40.94%, with investment income of -179,400 yuan and financial expenses of 542,400 yuan, while the gross profit margin is 22.45% [3] Group 2: Capital Flow - On February 25, 2026, the net outflow of main funds was 3.27 million yuan, accounting for 8.28% of the total transaction value, while retail investors saw a net inflow of 1.97 million yuan, representing 4.99% of the total transaction value [1] - The financing data indicates that on the same day, the financing buy amounted to 5.29 million yuan, while financing repayment was 6.86 million yuan, resulting in a net repayment of 1.57 million yuan [2] - The margin trading and securities lending balance is reported to be 140 million yuan [2]

Group 1 - The core point of the article is that Hongtong Medical reported a total of 8,585 shareholders as of February 13, 2026 [2]

Core Viewpoint - The company, Sichuan Portong Medical Equipment Group Co., Ltd., specializes in medical gas equipment and cleanroom systems, with a focus on providing comprehensive engineering solutions for medical institutions [3][7]. Business Overview - The main business activities of the company include the research, design, manufacturing, integration, and operation and maintenance services of medical gas equipment and cleanroom systems [3][7]. - The company's primary product revenue breakdown is as follows: cleanroom equipment and systems (55.69%), medical gas equipment and systems (37.30%), medical devices and other product sales (4.06%), operation and maintenance services (2.81%), and others (0.14%) [8]. Recent Developments - The company has developed the Portong Cloud Monitoring Platform, which utilizes advanced IoT technology to provide real-time monitoring solutions for medical equipment in hospitals [2]. - The company has been recognized as a "specialized, refined, distinctive, and innovative" small giant enterprise, indicating its strong innovation capabilities and market position [3]. Financial Performance - For the period from January to September 2025, the company reported a revenue of 344 million yuan, a year-on-year decrease of 30.06%, and a net profit attributable to shareholders of -10.21 million yuan, a year-on-year decrease of 150.92% [8]. - The company has distributed a total of 48.99 million yuan in dividends since its A-share listing [9]. Market Activity - On February 24, the company's stock rose by 1.64%, with a trading volume of 55.84 million yuan and a turnover rate of 3.29%, bringing the total market capitalization to 2.607 billion yuan [1]. - The stock has shown a net inflow of 899,700 yuan from major investors, indicating a lack of clear trends in major investor activity [4][5].

有投资者在互动平台向港通医疗提问："尊敬的董秘你好，请问截止至2026年2月10日收盘公司股东人数 为多少，谢谢！" 针对上述提问，港通医疗回应称："尊敬的投资者，您好！公司截至2026年2月10日股东总户数为8919 户，感谢您的关注。" 声明：市场有风险，投资需谨慎。本文为AI基于第三方数据生成，仅供参考，不构成个人投资建议。 来源：市场资讯 ...

Group 1 - The core viewpoint of the article highlights the recent stock price fluctuations of Kangtong Medical, with a notable decline in share price and net outflow of funds, indicating potential investor concerns [1] - As of February 11, the closing price was 25.44 yuan, down 0.70% from the previous day, with a trading volume of 3,882 million yuan and a turnover rate of 2.32% [1] - The company operates in brain-computer interfaces, smart medical devices, and medical equipment, showing potential applications in surgical environments [1] Group 2 - A recent report by the China Academy of Information and Communications Technology emphasizes the trend of AI medical equipment in precision medicine and grassroots healthcare, which may provide long-term benefits to the medical device sector [2] - The collaboration proposal between Nansha and Hong Kong to build a biopharmaceutical industry cluster may indirectly boost the attention on regional medical innovation enterprises [2] Group 3 - For the period from January to September 2025, the company's operating revenue was 344 million yuan, a year-on-year decrease of 30.06%, while the net profit attributable to shareholders was a loss of 10.21 million yuan, down 150.92% year-on-year [3] - The number of shareholders decreased by 4.48% compared to the previous period, indicating a slight increase in share concentration [3]

Core Viewpoint - The company, Sichuan Portong Medical Equipment Group Co., Ltd., specializes in medical gas equipment and cleanroom systems, with a focus on providing comprehensive engineering solutions for medical institutions [3]. Group 1: Company Overview - Sichuan Portong Medical Equipment Group Co., Ltd. was established on January 13, 1998, and went public on July 25, 2023 [7]. - The company's main business includes the research, design, manufacturing, integration, and operation services of medical gas equipment and cleanroom systems [3][7]. - The revenue composition of the company is as follows: cleanroom equipment and systems 55.69%, medical gas equipment and systems 37.30%, sales of medical devices and other products 4.06%, operation services 2.81%, and others 0.14% [8]. Group 2: Financial Performance - For the period from January to September 2025, the company achieved operating revenue of 344 million yuan, a year-on-year decrease of 30.06%, and a net profit attributable to the parent company of -10.21 million yuan, a year-on-year decrease of 150.92% [8]. - The company has distributed a total of 48.9973 million yuan in dividends since its A-share listing [9]. Group 3: Market Position and Recognition - The company has been recognized as a "specialized, refined, distinctive, and innovative" small giant enterprise, which is a prestigious title in the evaluation of small and medium-sized enterprises in China [3]. - The company is positioned within the pharmaceutical and biological industry, specifically in the medical device sector [8]. Group 4: Recent Developments - The company has developed the Portong Cloud Monitoring Platform, which utilizes advanced IoT technology to provide real-time monitoring solutions for medical equipment in hospitals [2]. - The company’s medical gas equipment and cleanroom systems are crucial for ensuring the safety and cleanliness standards required for brain-computer interface surgeries [2].